We measured bone mineral density (BMD) 
Introduction
When calcium absorbed from the diet is insufficient to offset obligatory fecal and urinary losses, calcium must be withdrawn from bone, which contains 99% of total body calcium stores (1) . Several investigators consider insufficiency of dietary calcium intake or of calcium absorption to be major risk factors for the development of osteoporosis (2, 3) . Although the recommended daily allowance for calcium is set at 800 mg/d (4), middle-aged and elderly American women have a mean intake of only 500 mg/d (5) .
Additionally, the Consensus Conference on Osteoporosis from the National Institutes of Health recommended that calcium intake be increased to 1,000 mg/d for premenopausal women and to 1,500 mg/d for postmenopausal women (6). This recommendation has received a great deal of attention in the media, and it is estimated that sales of calcium tablets in the United States should reach $166 million in 1987, an approximate doubling of sales in the last two years (7) .
Despite this popular enthusiasm, experimental studies documenting the role of calcium deficiency in the pathogenesis of osteoporosis and the value of calcium supplementation in the prevention ofit have given confficting results. Using metabolic balance methods, Nordin et al. (8) estimated that a calcium intake of 550 mg/d was required to prevent negative calcium balance. In contrast, Heaney et al. (9) estimated with combined radiocalcium kinetic and calcium balance studies that daily requirements were 1,000 mg for premenopausal women and 1,500 mg for postmenopausal women. In a large crosssectional survey, Garn (10) found no relationship between metacarpal cortical area and calcium intake. Matkovic et al. ( 11) found lower values for this cortical area in a Yugoslavian district with low calcium intake than in another district with a high intake. These differences were apparent in young adult bone and did not become larger with aging, suggesting that the main effect ofcalcium intake was during bone growth. Nilas et al. (12) found no relationship in postmenopausal women between rate of bone loss from the distal radius and dietary calcium consumption over a wide range of intakes. Four of six clinical trials (13) (14) (15) (16) (17) (18) found significant short-term slowing of bone loss from the appendicular skeleton when postmenopausal women received calcium supplements of at least 750 mg/d. In those trials in which a significant effect of calcium supplementation was demonstrated, however, the degree of retardation ofbone loss was less than that achieved by estrogen administration (14, 15, 17) . More recently, however, two studies (19, 20) found that administration of 1,500 mg/d of calcium supplements for 2 yr did not decrease rate of bone loss from lumbar spine as compared with a placebo-treated group of women in the immediate postmenopausal period.
Because of this uncertainty, we evaluated the relationship between dietary calcium intake and rates of change in bone in the axial and appendicular skeleton in normal women of various ages.
Methods
Experimental subjects and protocol. We measured bone mineral density (BMD)' at the midradius and lumbar spine in 106 normal women who were residents of Rochester, MN. Of these, 73 were from a stratified random sample selected from the community population as part of an ongoing epidemiologic study (group A). All subjects from the random sample were included provided they had been followed for > 2.5 yr, had at least three densitometry measurements, and had none ofthe exclusion criteria. The remainder were volunteers from the same population (group B). Mean age was 52 yr (range, 23-84 yr), and 61 were postmenopausal. Menopause was defined as absence of menses for at least 6 mo and serum estradiol level < 50 pg/ml. Normality was assessed by interview, review of each patient's medical record, and laboratory testing. All had normal values for serum calcium, phosphorus, creatinine, and alkaline phosphatase. All subjects were ambulatory. None had vertebral fractures on roentgenograms of the spinal column or a history of hip fracture. None was taking corticosteroids, anticonvulsive medication, thiazide diuretics, vitamin D in pharmaco-logic dosages, or calcium supplement of > 500 mg/d. None of the postmenopausal women was taking estrogen replacement therapy. Five of the premenopausal women were taking contraceptive hormones. None had any evident medical disease known to affect calcium metabolism. These exclusion criteria were maintained for the duration of the study.
Dietary calcium intake was assessed by a trained dietitian who interviewed each patient for 1 h and reviewed a 7-d dietary diary recorded by the subject. The dietary survey was made at the beginning of the period of observation of the 73 subjects in group A, whereas it was obtained at the end for the subjects in group B. Reproducibility of the estimate ofthe dietary calcium intake was assessed by repeating the interview and the 7-d dietary diary after an interval of 2 yr in 22 subjects (12 of these were in the present study and 10 were members of the ongoing epidemiologic study but were not included because they did not meet the criteria for normality). Stability of calcium intake over the period ofstudy was assessed by a questionnaire on use ofdairy products and calcium supplements (the principal sources ofcalcium in the diet). In the patients in the epidemiologic study, the questionnaire was completed at the end of the study and was compared with comparable items obtained by the dietitian's interview. In the remaining subjects, the stability of the calcium intake was assessed by comparing these same items in the dietary calcium interview obtained at the end of the study with estimates by the dietitian of use of these items at the beginning of the study.
Fasting-state blood samples were drawn for determination of serum sex steroid levels. For the premenopausal women, the blood sample was obtained between days 7 and 10 of the menstrual cycle. Bone densitometry was repeated on one or more occasions. The interval between the first and last measurements ranged from 2.6 to 6.6 yr (median, 4.1 yr). The number of measurements per subject ranged from three to nine (median, four measurements).
All subjects gave their informed consent. The experimental protocol was reviewed and approved by the Mayo Institutional Review Board. Descriptive characteristics of the experimental subjcts are given in Table I .
Laboratory methods. BMD of the midradius was measured by single-photon absorptiometry as described (21) except that the scanner was modified to permit rectilinear scanning. The recorded value was the mean of five scan passes at intervals of 0.1 cm. Reproducibility ([SD/mean of repeat measurements] X 100) was 1%. BMD of the lumbar spine was measured by dual-photon absorptiometry (22) ; reproducibility was 1.7% (23) . Serum estrone and estradiol were measured by described radioimmunoassay techniques (24) .
Statistical methods. To estimate rates of BMD change, a linear regression was fitted for each patient. These regressions used BMD as the dependent variable and time, in years, from the patient's entry into the study as the independent variable. The slope was expressed as g/cm2 per yr and g/cm per yr for the lumbar spine and midradius sites, respectively. Each slope was divided by the predicted BMD value at the midpoint of the time interval for which the patient was under study and multiplied by 100 to obtain the percent change per year (%/yr). The slopes and the percentage change per year are highly correlated (r = 0.984 for midradius and r = 0.981 for lumbar spine). Thus, we elected to express results as percent change per year for the sake of simplicity.
To evaluate the association between dietary calcium intake and rate of BMD change (%/yr), we examined both the overall relationship as well as the adjusted effect after controlling for other significant variables. To assess the overall relationship, zero-order correlation was used. The sample was also divided into four groups by quartile of calcium intake and rates of BMD change were compared across groups. To assess the adjusted effect of calcium intake on rates of BMD change, we first used stepwise multiple regression with backward elimination to select significant control variables before the inclusion of calcium intake in the model. In the process of variable selection, as well as in the final model, various interaction terms and the distribution of residuals were examined, and the assumptions of normality and homoskedasticity of the residuals were verified for each of them. The the relationship between rate of BMD change and calcium intake. The model was adjusted for these variables by entering each term into it and adjusting accordingly before testing for an effect of calcium intake on rates of change in BMD using partial correlation coefficients. The variables considered for this model were age, age squared, serum estrone, serum estradiol, and menopausal status. The square of age was included because in a previous study (20) we found that the rate of BMD change for the lumbar spine was related to age in a parabolic fashion. For lumbar spine, the interaction ofage and menopausal status was significant. For midradius, the agesquared term and its interaction with menopause were significant in a model of age, age-squared, menopausal status, and two-way interactions. The interaction terms between age and menopausal status indicated that the effects of age on the rate of BMD change were different between pre-and postmenopausal women. Thus, the effect of calcium intake was assessed separately in pre-and postmenopausal women. Of course, once menopausal status was taken into account, the values for serum estrone and estradiol were not significant because both were highly correlated with menopausal status (r = -0.58, P < 0.001 for serum estrone; r = -0.66, P < 0.001 for serum estradiol). Calcium intake was then incorporated into the regression model for rate ofchange by menopausal status. For midradius, there was a marginally significant trend (P = 0.08) for an inverse correlation between change in BMD and calcium intake in the premenopausal women (the higher the intake the more negative the rate of change). For lumbar spine, there was no suggestion of a relationship for either pre-or postmenopausal women. Thus, even after controlling for all salient variables, a significant relationship between calcium intake and rate of change in BMD could not be demonstrated for either the midradius or lumbar spine. Table III gives the power calculations for the ability of the model to detect these changes. The values presented are the values for p, the population correlation coefficient, which if these or higher values existed would yield statistically significant results 80 or 90% of the time (assuming that the samples ofthe sizes actually in hand were used to test the hypothesis of no association at a = 0.05). These values have been adjusted for measurement errors, i.e., the proportion of intrasubject variance in relation to intersubject variance for both rate of change in BMD and calcium intake. The intra-and intersubject variance of calcium intake were estimated based on 12 subjects with repeated measurements. The shares of intra-and intersubject variance are about 52 vs. 48% for rate ofchange in lumbar spine, 57 vs. 48% for midradius and 20 vs. 80% for calcium intake.
Discussion
Our data do not support the hypothesis that the rate of bone loss in adult women has a major relationship to dietary calcium intake over the wide range of values found in the normal American diet. If such a major relationship were present, we believe that it would have been detected by our experimental design. First, the bone densitometry methods that we used were highly precise, and we observed individual subjects for a sufficient interval to obtain a good estimate of individual rate of change in the axial and the appendicular skeleton. Second, we assessed calcium intake by combining two reliable survey methods-interview by a trained dietitian and 7-day food diary. Using a somewhat less precise method, we found that the mean intake of dairy products and calcium supplements, the two major sources of calcium, did not change during the study interval. Third, we controlled for the potentially con- (27, 28) . Thus, the questions of the relationship of dietary calcium to bone loss and the value of high calcium intake in prevention of osteoporosis should be considered open, and further studies should be conducted. Studies relating the amount of absorbed calcium to bone loss in women of various ages and assessing the effect of calcium supplements on rates of bone loss from the vertebrae are particularly needed.
